Identification Properties Safety Data Specifications andamp ; Other Information Links Identification CAS Number 145040-37-5
Name Candesantan Cilexetil
Synonyms 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate [
ACD /
IUPAC Name] 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazol-7-carboxylat [German] [
ACD /
IUPAC Name] 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazol-7-carboxylat [German] 145040-37-5 [
RN ] 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester [
ACD /Index Name] 2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester 2-Éthoxy-1-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] [
ACD /
IUPAC Name] 2-éthoxy-1-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] Candesartan cilexetil [
JAN ] [
USAN ]
R85M2X0D68 UNII :
R85M2X0D68 (±)-1-Hydroxyethyl 2-Ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate Cyclohexyl Carbonate (Ester) (2-ethoxy-1-{[4-(2-(
1H-1 ,2,3,4-tetraazol-5-yl)phenyl)phenyl]methyl}benzimidazol-7-ylcarbonyloxy)ethyl cyclohexyloxyformate [145040-37-5] 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethox 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2-(2h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(
1H-1 ,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)-, hydroxide, inner salt, (±)- 2-?
ETHOXY- ?1-?[[2′-?(
2H- ?
TETRAZOL- ?5-?
YL )[1,?1′-?
BIPHENYL ]-?4-?
YL ]
METHYL ]-?1-?[[(
CYCLOHEXYLOXY )
CARBONYL ]
OXY ]
ETHYL ESTER- ?
1H- ?
BENZIMIDAZOLE- ?7-?
CARBOXYLIC ACID 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester 2-Ethoxy-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid [
ACD /
IUPAC Name] 2-Ethoxy-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester 2-Ethoxy-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester 7689-03-4 [
RN ] Amias [Trade name] Atacand [Trade name] Blopress [Trade name]
BR-75900 C077793 Camptothecine Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester Candesartan celexetil candesartan cilexetil(?????????)
CANDESARTAN CILEXITIL DD6672500 H212 /91 Kenzen
MFCD00871371 [
MDL number] Parapres Pharmakon1600-01504261 Racanda Ratacand [Trade name]
TCV 116 |
TCV116 TCV-116 ;
TCV116 ;
TCV 116;Atacand
TCY 116
TL8000995 Molecular Structure SMILES CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5)C(=O)
OC (C)
OC (=O)
OC6CCCCC6 StdInChI InChI=
1S /
C33H34N6O6 /c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,
24H ,3-6,10-11,
20H2 ,1-2H3,(H,35,36,37,38)
StdInChIKey GHOSNRCGJFBJIB-UHFFFAOYSA-N Molecular Formula C33H34N6O6 Molecular Weight 610.66
MDL Number MFCD00871371 Safety Data GHS08 , GHS09 Signal Word Warning
Hazard Statements H361-H400 Precautionary Statements P280 RIDADR UN 3077 9 /
PGIII WGK Germany 3
Specifications and Other Information of Our Candesantan Cilexetil CAS 145040-37-5 Standard EP ,
USP GMP CFDA Basic Patent Situation US expiry date20120604 EU expiry date20110419 (20120428) JP expiry date20160428
Package According to customer requirements to packaging
Storage Under the room temperature and away from light
Application Used as Angiotensin
II Receptor Antagonist
Links This product is developed by our
RD company Caming Pharmaceutical Ltd(
http://www.caming.com ), and here is the corresponding link
http://www.caming.com/candesantan-cilexetil-cas-145040-37-5/ Quick Inquiry Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).